00917nam a22002657a 4500 BD-DhUL 20191024142718.0 191023s2014 flua|||| b||| 001 0 eng 9781439867945 (hbk) BD-DhUL BD-DhUL 615.7040287 BEN Benefit-risk assessment in pharmaceutical research and development / edited by Andreas Sashegyi, James Felli, and Rebecca Noel. Boca Raton : CRC Press, 2014. xxii, 194 p. : ill. (some col.) ; 24 cm. GBP 68.99 Chapman &Hall/CRC biostatistics series Glossary: p. 185-186. Includes bibliographical references and index. Drugs - Testing. Health risk assessment. Sashegyi, Andreas. ed. Felli,James. jt. ed. Noel, Rebecca. jt. ed. ddc BK 250483 250483 0 0 ddc 0 615_704028700000000_BEN 0 NFIC 381337 DUSL DUSL GEN 2019-04-30 Purchased 615.7040287 BEN 515663 2019-10-23 1 2019-10-23 BK Clinical Pharmacy and Pharmacology 0 0 ddc 0 615_704028700000000_BEN 0 NFIC 381338 DUSL DUSL GEN 2019-04-30 Purchased 615.7040287 BEN 515664 2019-10-23 2 2019-10-23 BK Clinical Pharmacy and Pharmacology